The P3 in 'ecstasy' polydrug users during response inhibition and execution

Journal of Psychopharmacology

Volumn 19, Issue 5, 2005, Pages 504-512

  Gamma, Alex ^a   Brandeis, Daniel ^b   Brandeis, Ruven ^b   Vollenweider, Franz X ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Drug abuse; Ecstasy; ERP; MDMA; P3; Response inhibition

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; AGE; ARTICLE; BEHAVIOR CONTROL; CLINICAL ARTICLE; CONTROLLED STUDY; EDUCATION; ELECTRODE; EVENT RELATED POTENTIAL; FEMALE; HUMAN; IMPULSIVENESS; MALE; MULTIPLE DRUG ABUSE; NERVE CELL INHIBITION; NEUROPHYSIOLOGY; PRIORITY JOURNAL; SUBSTANCE ABUSE;

ADULT; ANALYSIS OF VARIANCE; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURAL INHIBITION; NEUROPSYCHOLOGICAL TESTS; PSYCHOPHARMACOLOGY; REACTION TIME; STREET DRUGS;

EID: 25844471511     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881105056535     Document Type: Article

References (52)

1. Banaschewski T, Brandeis D, Heinrich H, Albrecht B, Brunner E, Rothenberger A (2004) Questioning inhibitory control as the specific deficit of ADHD - evidence from brain electrical activity. J Neural Transm 111: 841-864
2. Begleiter H, Porjesz B (1999) What is inherited in the predisposition toward alcoholism? A proposed model. Alcohol Clin Exp Res 23: 1125-1135
3. Begleiter H, Porjesz B, Bihari B, Kissin B (1984) Event-related brain potentials in boys at risk for alcoholism. Science 225: 1493-1496
4. Berg P, Scherg M (1994) A multiple source approach to the correction of eye artifacts. Electroenceph Clin Neurophysiol 90(3): 229-241
5. Brandeis D, van Leeuwen T H, Steger J, Imhof K, Steinhausen H C (2002) Mapping brain functions of ADHD children. In Hirata K, Koga Y, Nagata K, Yamazaki K (eds), Recent Advances in Human Brain Mapping. Elsevier, Amsterdam
6. Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, Wilke F, Wartberg L, Zapletalova P, Clausen M (2003) Long-term effects of 'ecstasy' use on serotonin transporters of the brain investigated by PET. J Nucl Med 44: 375-384
7. Butler G K, Montgomery A M (2004) Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use. Drug Alcohol Depend 76: 55-62
8. Croft R J, Klugman A, Baldeweg T, Gruzelier J H (2001) Electrophysiological evidence of serotonergic impairment in long-term MDMA ('Ecstasy') users. Am J Psychiatry, 158: 1687-1692
9. Croft R J, Mackay A J, Mills A T, Gruzelier JGH (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153: 373-379
10. Dafters R I, Duffy F, O'Donnell P J, Bouquet C (1999) Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence. Psychopharmacology 145: 82-90
11. Dafters R I, Hoshi R, Talbot A C (2003) Contribution of cannabis and MDMA ('ecstasy') to cognitive changes in long-term poly drug users. Psychopharmacology 173: 405-410
12. Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E (2004) Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation. Psychopharmacology 173: 398-404
13. Daumann J, Pelz S, Becker S, Tuchtenhagen F, Gouzoulis-Mayfrank E (2001) Psychological profile of abstinent recreational ecstasy (MDMA) users and significance of concomitant cannabis use. Hum Psychopharmacol Clin Exp 16: 627-633
14. Evenden J L (1999) Varieties of impulsivity. Psychopharmacology 146: 348-361
15. Fallgatter A J, Bartsch A J, Herrmann M J (2002) Electrophysiological measurements of anterior cingulate function. J Neural Transm 109: 977-988
16. Fallgatter A J, Brandeis D, Strik W K (1997) A robust assessment of the NoGo-Anteriorisation of P300 microstates in a cued continuous performance test. Brain Topogr 9(4): 295-302
17. Fallgatter A J, Jatzke S, Bartsch A J, Hamelbeck B, Lesch K P (1999) Serotonin transporter promoter polymorphism influences topography of inhibitory motor control. Int J Neuropsychopharmacol 2: 115-120
18. Fallgatter A J, Muller T J (2001) Electrophysiological signs of reduced prefrontal response control in schizophrenic patients. Psychiat Res 107: 19-28
19. 15O]-PET study. J Clin Psychopharmacol 21: 66-71
20. Gamma A, Frei E, Lehmann D, Pascual-Marqui R D, Hell D, Vollenweider F X (2000) Mood state and brain electric activity in ecstasy users. Neuroreport 11: 157-162
21. Gamma A, Liechti M E (2002) The psychophysiology of substance-related disorders. In D'haenen H, den Boer J A, Willner P (eds), Biological Psychiatry. John Wiley, Chichester
22. Gijsman H J, van Gerven JMA, Verkes R J, Schoemaker R C, Pieters M S M, Pennings EJM, Hessing T J, Cohen A F (2002) Saccadic peak velocity and EEG as end-points for aserotonergic challenge test. Hum Psychopharmacol Clin Exp 17: 83-89
23. Gouzoulis-Mayfrank E, Becker S, Pelz S, Tuchtenhagen F, Daumann J (2002) Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: Is it ecstasy or cannabis? Biol Psychiatry 51: 766-769
24. Green A R, Mechan A O, Elliott J M, O'Shea E, Colado M I (2003) The pharmacology and clinical pharmacology of 3,4-methylene-dioxymethamphetamine (MDMA, 'ecstasy') Pharmacol Rev 55: 463-508
25. Halgren E, Stapleton J M, Smith M, Altafullah I (1986) Generators of the human scalp P3(s). In Cracco R Q, Bodis-Wollner I (eds), Evoked Potentials. Alan Liss, New York
26. Herrmann M J, Jacob C, Unterecker S, Fallgatter A J (2003) Reduced response-inhibition in obsessive-compulsive disorder measured with topographic evoked potential mapping. Psychiatry Res 120: 265-271
27. Hill S Y, Shen S, Locke J, Steinhauer S R, Konicky C, Lowers L, Connolly J (1999) Development delay in P300 production in children at high risk for developing alcohol-related disorders. Biol Psychiatry 46: 970-980
28. Iacono W G, Carlson S R, Malone S M, McGue M (2002) P3 event-related potential amplitude and the risk for disinhibitory disorders in adolescent boys. Arch Gen Psychiatry 59: 750-757
29. Iacono W G, Carlson S R, Taylor J, Elkins I J, McGue M (1999) Behavioral disinhibition and the development of substance-use disorders: findings from the Minnesota Twin Family Study. Dev Psychopathol 11: 869-900
30. Kish S J (2002) How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacol Biochem Behav 71: 845-855
31. Lehmann D, Skrandies W (1980) Reference-free identification of components of checkerboard-evoked multichannel potential fields. Electroenceph Clin Neurophysiol 48: 609-621
32. Lieb R, Schuetz C G, Pfister H, von Sydow K, Wittchen H-U (2002) Mental disorders in ecstasy users: a prospective-longitudinal investigation. Drug Alcohol Depend 68: 195-207
33. Morgan M J (1998) Recreational use of Ecstasy (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19: 252-264
34. Morgan M J, McFie L, Fleetwood L H, Robinson J A (2002) Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology 159: 294-303
35. Parrott A C (2000) Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioral indices of change. Neuropsychobiology 24: 17-24
36. Parrott A C, Sisk E, Turner JJD (2000) Psychobiological problems in heavy 'Ecstasy' (MDMA) polydrug users. Drug Alcohol Depend 60: 105-110
37. Polich J, Pollock V E, Bloom F E (1994) Meta-analysis of P300 amplitude from males at risk for alcoholism. Psychol Med 115: 55-73
38. Reneman L, Lavalaye J, Schmand B, de Wolff F A, van den Brink W, den Heeten G J, Booij J (2001) Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylene-dioxymethamphetamine (MDMA or 'ecstasy'). Arch Gen Psychiatry 58: 901-906
39. Ricaurte G A, Yuan J, McCann D U (2000) (±)3,4-methylene- dioxymethamphetamine ('ecstasy')-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42: 5-10
40. Roberts L E, Rau H, Lutzenberger W, Birnbaumer N (1994) Mapping P300 waves onto inhibition: Go/No-Go discrimination. Electroenceph Clin Neurophysiol 92: 44-55
41. Rockstroh B, Muller M, Cohen R, Elbert T (1992) Probing the functional brain state during P300-evocation. J Psychophysiol 6: 175-184
42. Semple D M, Ebmeier K P, Glabus M F, O'Carroll R E, Johnstone E C (1999) Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. Br J Psychiatry 175: 63-69
43. Simon N G, Mattick R P (2002) The impact of regular ecstasy use on memory function. Addiction 97: 1523-1529
44. Simson R, Vaughan H G, Ritter W (1977) The scalp topography of potentials in auditory and visual Go/No-Go tasks. Electroenceph Clin Neurophysiol 43: 864-875
45. Solowij N, Mitchie P T, Fox A M (1991) Effects of long-term cannabis use on selective attention: an event-related potentia study. Pharmacol Biochem Behav 40: 683-688
46. Solowij N, Michie P T, Fox A M (1995) Differential impairments of selective attention due to frequency and duration of cannabis use. Biol Psychiatry 37: 731-739
47. Strik W, Fallgatter AJ, Brandeis D, Pascual-Marqui R D (1998) Three- dimensional tomography of event-related potentials during response inhibition: evidence of phasic frontal lobe activation. Electroenceph Clin Neurophysiol 108: 406-413
48. Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology 167: 85-96
49. Tuchtenhagen F, Daumann J, Norra C, Gobbele R, Becker S, Pelz S, Sass H, Buchner H, Gouzoulis-Mayfrank E (2000) High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacology 22: 608-617
50. van Leeuwen T H, Brandeis D, Overtoom K E, Pascual-Marqui R D, Van't Klooster B, Rothenberger A, Sergeant J A, Steinhausen H C (1998) The continuous performance test revisited with neuroelectric brain mapping: impaired orienting in children with attention deficits. Behav Brain Res 94: 97-110
51. Verkes R J, Gijsman H J, Pieters M S, Schoemaker R C, de Visser S, Kuijpers M, Pennings E J, de Bruin D, van de Wijngaart G, van Gerven J M, Cohen A F (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153: 196-202
52. Woodward S H, Brown W S, Marsh J T, Dawson M E (1991) Probing the time-course of the auditory oddball P3 with secondary reaction time. Psychophysiology 28: 609-618